References
- Ader M, Bergman RN. (1990). Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol, 258:E1020–32
- Aguirre V, Werner ED, Giraud J, et al. (2002). Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem, 277:1531–7
- Al-Hashem F, Shatoor A, Sakr H, et al. (2012). Co-administration of vitamins E and C protect against stress-induced hepatorenal oxidative damage and effectively improve lipid profile at both low and high altitudes. Afr J Biotechnol, 11:10416–23
- Al-Hashem F, Shatoor A, Sakr H, et al. (2012). Inhibited thyroid function, impaired lipid metabolism and increases tissue oxidative stress in rats native to high altitude. Bahrain Med Bull, 34:1–10
- Andres R, Cader G, Zierler KL. (1956). The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J Clin Investig, 35:671–82
- Arias EB, Kim J, Funai K, Cartee GD. (2007). Prior exercise increases phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle. Am J Physiol, 292:E1191–200
- Arsham AM, Howell JJ, Simon MC. (2003). A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem, 278:29655–60
- Asano T, Katagiri H, Tsukuda K, et al. (1992). Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes, 41:22–5
- Baracco R, Mohanna S, Seclen S. (2006). Determination of insulin sensitivity through the HOMA method in adult populations living at the highlands and at sea level. Rev Med Hered, 17:206–11
- Baron AD, Kolterman OG, Bell J, et al. (1985). Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Investig, 76:1782–8
- Brugarolas J, Lei K, Hurley RL, et al. (2004). Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev, 18:2893–904
- Burkhardt BR, Parker MJ, Zhang YC, et al. (2005). Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. FEBS Lett, 579:5759–64
- Bunn HF, Poyton RO. (1996). Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev, 76:839–85
- Capozza F, Combs TP, Cohen AW, et al. (2005). Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol, 288:C1317–31
- Cartee GD, Wojtaszewski JF. (2007). Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl Physiol Nutr Metab, 32:557–66
- Chen YC, Lee SD, Kuo CH, Ho L. (2011). The effects of altitude training on the AMPK-related glucose transport pathway in the red skeletal muscle of both lean and obese Zucker rats. High Alt Med Biol, 12:371–8
- Carlson CJ, White MF, Rondinone CM. (2004). Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem Biophys Res Commun, 316:533–9
- Corradetti MN, Inoki K, Bardeesy N, et al. (2004). Regulation of the TSC pathway by LKB1: Evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev, 18:1533–8
- Castillo O, Woolcott OO, Gonzales E, et al. (2007). Residents at high altitude show a lower glucose profile than sea-level residents throughout 12-hour blood continuous monitoring. High Alt Med Biol, 8:307–11
- Dan HC, Sun M, Yang L, et al. (2002). Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem, 277:35364–70
- deLange P, Moreno M, Silvestri E, et al. (2007). Fuel economy in food-deprived skeletal muscle: Signaling pathways and regulatory mechanisms. Faseb J, 21:3431–41
- DeYoung MP, Horak P, Sofer A, et al. (2008). Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev, 1522:239–51
- Dufour S, Lebon V, Shulman GI, Petersen KF. (2009). Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans. Am J Physiol Endocrinol Metab, 297:E231–5
- Foretz M, Hébrard S, Leclerc J, et al. (2010). Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Investig, 120:2355–69
- Gerich JE, Meyer C, Woerle HJ, Stumvoll M. (2001). Renal gluconeogenesis: Its importance in human glucose homeostasis. Diabetes Care, 24:382–91
- Guertin DA, Sabatini DM. (2007). Defining the role of mTOR in cancer. Cancer Cell, 12:9–22
- Harrington LS, Findlay GM, Gray A, et al. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol, 166:213–23
- Iyer NV, Kotch LE, Agani F, et al. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev, 12:149–62
- Kockeritz L, Doble B, Patel S, Woodgett JR. (2006). Glycogen synthase kinase-3 – an overview of an over-achieving. Curr Drug Targets, 7:1377–88
- Lee JW, Bae SH, Jeong JW, et al. (2004). Hypoxia-inducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp Mol Med, 36:1–12
- Leturque A, Brot‐Laroche E, Le Gall M. (2009). GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab, 296:E985–92
- Lin HV, Accili D. (2011). Hormonal regulation of hepatic glucose production in health and disease. Cell Metab, 14:9–19
- Lindgarde F, Ercilla MB, Correa LR, Ahren B. (2004). Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians. High Alt Med Biol, 5:27–31
- LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. (2008). Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resist Update, 11:32–50
- Marinho R, Ropelle ER, Cintra DE, et al. (2012). Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss. J Cell Physiol, 227:2917–26
- Ozes ON, Akca H, Mayo LD, et al. (2001). A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci USA, 98:4640–5
- Prada PO, Coelho MS, Zecchin HG, et al. (2005). Low salt intake modulates insulin signaling, JNK activity and IRS-1ser307 phosphorylation in rat tissues. J Endocrinol, 185:429–37
- Pilkis SJ, Granner DK. (1992). Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol, 54:885–909
- Postic C, Burcelin R, Rencurel F, et al. (1993). Evidence for a transient inhibitory effect of insulin on GLUT2 expression in the liver: Studies in vivo and in vitro. Biochem J, 293:119–24
- Puigserver P, Rhee J, Donovan J, et al. (2003). Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature, 423:550–5
- Qu S, Altomonte J, Perdomo G, et al. (2006). Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology, 147:5641–52
- Regazzetti C, Bost F, Le Marchand-Brustel Y, et al. (2010). Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes. J Biol Chem, 285:5157–64
- Rencurel F, Waeber G, Antoine B, et al. (1996). Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver. Biochem J, 314:903–9
- Ropelle ER, Pauli JR, Cintra DE, et al. (2009). Acute exercise modulates the Foxo1/PGC-1alpha pathway in the liver of diet-induced obesity rats. J Physiol, 587:2069–76
- Sarbassov DD, Ali SM, Sabatini DM. (2005). Growing roles for the mTOR pathway. Curr Opin Cell Biol, 17:596–603
- Saltiel AR, Kahn CR. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414:799–806
- Shaw RJ, Bardeesy N, Manning BD, et al. (2004). The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell, 6:91–9
- Srinivasana S, Dunn GF. (2011). Stabilization of hypoxia-inducible factor-1α in buffer containing cobalt chloride for western blot analysis. Anal Biochem, 416:120–2
- Stroka DM, Burkhardt T, Desbaillets I, et al. (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. Faseb J, 15:2445–53
- Tremblay F, Brûlé S, Hee Um S, et al. (2007). Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA, 104:14056–61
- Wang HY, Ducommun S, Quan C, et al. (2013). AS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues. Biochem J, 449:479–89
- White MF. (2003). Insulin signaling in health and disease. Science, 302:1710–11
- Woolcott OO, Ader M, Bergman RN. (2015). Glucose homeostasis during short-term and prolonged exposure to high altitudes. Endocr Rev, 36:149–73